cebranopadol (TRN-228) - Tris Pharma
ALLEVIATE1: A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (clinicaltrials.gov) - Aug 9, 2024 - P3 | N=300 | Not yet recruiting | Sponsor: Tris Pharma, Inc. 
New P3 trial • Aesthetic Medicine • Pain
http://clinicaltrials.gov/ct2/show/NCT06545097
 
Aug 9, 2024
 
Prev Next